A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer

INTRODUCTION: Current treatment options for advanced esophagogastric cancer (AEGC) are still unsatisfactory. The aim of this prospective phase Ib/II study was to evaluate the safety and efficacy of a novel regimen, AVDCX, consisting of weekly docetaxel and cisplatin together with capecitabine and be...

Descripción completa

Detalles Bibliográficos
Autores principales: Brenner, Baruch, Sarfaty, Michal, Purim, Ofer, Kundel, Yulia, Amit, Limor, Abramovich, Amir, Sadeh Gonik, Udi, Idelevich, Efraim, Gordon, Noa, Medalia, Gal, Sulkes, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938513/
https://www.ncbi.nlm.nih.gov/pubmed/27390847
http://dx.doi.org/10.1371/journal.pone.0157548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938513/
https://www.ncbi.nlm.nih.gov/pubmed/27390847
http://dx.doi.org/10.1371/journal.pone.0157548

Ejemplares similares